Keyes Jason A
CIK 0001678152
Chief Financial OfficerDirector
Filings
15
Latest May 22, 2026
Issuers covered
3
Showing
15 of 15
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 67% | -7.3% | +7.9% | +20.6% | -72.2% |
| 90 days | 6 | 67% | +8.8% | +12.3% | +38.2% | -29.4% |
| 180 days | 6 | 83% | +28.7% | +32.2% | +44.1% | -1.3% |
| 365 days | 6 | 50% | -4.6% | +1.0% | +75.7% | -89.9% |
Issuers
Companies where Keyes Jason A has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| EQ | Equillium, Inc. | 11 | Feb 19, 2025 |
| ACTU | Actuate Therapeutics, Inc. | 3 | May 22, 2026 |
| CARM | Carisma Therapeutics Inc. | 1 | Jun 24, 2022 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|